A key protein involved in driving forward the progression of MS has been identified by researchers.
The findings, published in the journal Nature Communications, suggests modern medicine is a step closer to being able to block the development of the disease.
The protein, CCR2, is a specific 'chemokine receptor' - and is involved in moving the body's immune response cells, the T-cells, around the body when persistent infections are attacking the body.
But the T-cells are also called on when a person suffers from an autoimmune disease like MS, attacking the body's own tissues.
They found that while blocking CCR6 makes MS symptoms worse, blocking CCR2 and diminishing its influence over T-cells could control the disease's progression.
http://m.heraldscotland.com/news/139...r_MS_patients/
The findings, published in the journal Nature Communications, suggests modern medicine is a step closer to being able to block the development of the disease.
The protein, CCR2, is a specific 'chemokine receptor' - and is involved in moving the body's immune response cells, the T-cells, around the body when persistent infections are attacking the body.
But the T-cells are also called on when a person suffers from an autoimmune disease like MS, attacking the body's own tissues.
They found that while blocking CCR6 makes MS symptoms worse, blocking CCR2 and diminishing its influence over T-cells could control the disease's progression.
http://m.heraldscotland.com/news/139...r_MS_patients/
Comment